Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP9 | P14780 | 4/20 | 0.45 |
| ▸ | MMP2 | P08253 | 3/20 | 0.45 |
| ▸ | MMP1 | P03956 | 2/20 | 0.45 |
| ▸ | MMP8 | P22894 | 2/20 | 0.45 |
| ▸ | VIPR2 | P41587 | 9/20 | 0.45 |
| ▸ | PSEN1 | P49768 | 1/20 | 0.42 |
| ▸ | PSEN2 | P49810 | 1/20 | 0.42 |
| ▸ | APH1B | Q8WW43 | 1/20 | 0.42 |
| ▸ | NCSTN | Q92542 | 1/20 | 0.42 |
| ▸ | APH1A | Q96BI3 | 1/20 | 0.42 |
| ▸ | PSENEN | Q9NZ42 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9565615 | 0.96 | MMP9 (0.46) | MMP9MMP2MMP1MMP8VIPR2 | |
| SCHEMBL9565612 | 0.96 | MMP9 (0.46) | MMP9MMP2MMP1MMP8VIPR2 | |
| SCHEMBL9565610 | 0.96 | MMP9 (0.46) | MMP9MMP2MMP1MMP8VIPR2 | |
| SCHEMBL9565567 | 0.94 | MMP9 (0.44) | MMP9MMP2MMP1MMP8VIPR2 | |
| SCHEMBL9565625 | 0.94 | MMP9 (0.44) | MMP9MMP2MMP1MMP8VIPR2 | |
| SCHEMBL9565568 | 0.94 | MMP9 (0.44) | MMP9MMP2MMP1MMP8VIPR2 | |
| SCHEMBL9565586 | 0.94 | MMP9 (0.44) | MMP9MMP2MMP1MMP8VIPR2 | |
| SCHEMBL9565585 | 0.94 | MMP9 (0.44) | MMP9MMP2MMP1MMP8VIPR2 | |
| SCHEMBL9565588 | 0.94 | MMP9 (0.44) | MMP9MMP2MMP1MMP8VIPR2 | |
| SCHEMBL9565641 | 0.94 | MMP9 (0.44) | MMP9MMP2MMP1MMP8VIPR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0528661-A2 | HIV protease inhibitors with N-terminal polyether substituents | MERCK & CO. INC. (US) | 1993-02-24 | — | — | EP | claimed |
| EP-0528661-A2 | HIV protease inhibitors with N-terminal polyether substituents | MERCK & CO. INC. (US) | 1993-02-24 | — | — | EP | disclosed |